GUILLERMO GARCIA-MANERO to Cell Line
This is a "connection" page, showing publications GUILLERMO GARCIA-MANERO has written about Cell Line.
Connection Strength
0.141
-
Identification of the Benzoimidazole Compound as a Selective FLT3 Inhibitor by Cell-Based High-Throughput Screening of a Diversity Library. J Med Chem. 2022 02 24; 65(4):3597-3605.
Score: 0.030
-
Clinico-pathologic characteristics and outcomes of the World Health Organization (WHO) provisional entity de novo acute myeloid leukemia with mutated RUNX1. Mod Pathol. 2020 09; 33(9):1678-1689.
Score: 0.026
-
Investigating protein patterns in human leukemia cell line experiments: A Bayesian approach for extremely small sample sizes. Stat Methods Med Res. 2020 04; 29(4):1181-1196.
Score: 0.025
-
ITD mutation in FLT3 tyrosine kinase promotes Warburg effect and renders therapeutic sensitivity to glycolytic inhibition. Leukemia. 2017 10; 31(10):2143-2150.
Score: 0.021
-
An MDS xenograft model utilizing a patient-derived cell line. Leukemia. 2014 May; 28(5):1142-5.
Score: 0.017
-
K-ras(G12V) transformation leads to mitochondrial dysfunction and a metabolic switch from oxidative phosphorylation to glycolysis. Cell Res. 2012 Feb; 22(2):399-412.
Score: 0.014
-
Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course. Cancer. 2002 May 01; 94(9):2416-25.
Score: 0.008